UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009598
Receipt number R000011258
Scientific Title Examination of the protective efficacy for vein thromboembolism (VTE) and safety of enoxaparin sodium after the abdominal surgery
Date of disclosure of the study information 2012/12/25
Last modified on 2012/12/20 22:49:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of the protective efficacy for vein thromboembolism (VTE) and safety of enoxaparin sodium after the abdominal surgery

Acronym

Examination of enoxaparin sodium after the abdominal surgery

Scientific Title

Examination of the protective efficacy for vein thromboembolism (VTE) and safety of enoxaparin sodium after the abdominal surgery

Scientific Title:Acronym

Examination of enoxaparin sodium after the abdominal surgery

Region

Japan


Condition

Condition

colon cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We examine the protective efficacy of VTE and the risk of bleeding of enoxaparin sodium after the surgery and the bleeding.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Outbreak frequency of symptomatic PTE or VTE judged by imaging study

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Case of surgery targeted for the VTE prevention

Key exclusion criteria

1) The patient who bleeds
2 thrombocytopenia
3) Patient having the complications that may bleed(including a gastrointestinal ulcer, gastrointestinal diverticulitis, colitis, acute bacterial endocarditis, seriously ill high blood pressure, severe diabetes, the DIC).
4) Patient with impaired severe liver function
5) Sensitivity to danaparoid, heparin, low molecular weight heparin.
6) The patient who has the past of cerebral hemorrhage
7) The patient who received the operation of the central nervous system or ophthalmology within three months before registration of the final examination

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Aoki Jun

Organization

Juntendo University

Division name

Department of Coloproctological Surgery

Zip code


Address

3-1-3, Hongo, Bunkyo-ku, Tokyo, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Juntendo University

Division name

Department of Coloproctological Surgery

Zip code


Address


TEL


Homepage URL


Email

jaoki@juntendo.ac.jp


Sponsor or person

Institute

Department of Coloproctological Surgery
Juntendo University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Coloproctological Surgery
Juntendo University Faculty of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 12 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2012 Year 11 Month 30 Day

Date of IRB


Anticipated trial start date

2012 Year 12 Month 25 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Examination non-enforcement


Management information

Registered date

2012 Year 12 Month 20 Day

Last modified on

2012 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011258


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name